Salvianolic acid b induces apoptosis in human glioma U87 cells through p38-mediated ROS generation

Cellular and Molecular Neurobiology

Volumn 33, Issue 7, 2013, Pages 921-928

  Wang, Zi Shu ^a   Luo, Peng ^b   Dai, Shu Hui ^b   Liu, Zao Bin ^b   Zheng, Xin Rui ^b   Chen, Tao ^b,c  

^a BENGBU MEDICAL COLLEGE   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c The 123th Hospital of PLA   (China)

Author keywords

Apoptosis; p38; Reactive oxygen species; Salvianolic acid B

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN P53; REACTIVE OXYGEN METABOLITE; SALVIANOLIC ACID B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL DEATH; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME INACTIVATION; ENZYME PHOSPHORYLATION; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; WESTERN BLOTTING; XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BENZOFURANS; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; ENZYME ACTIVATION; GLIOMA; HUMANS; MICE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; REACTIVE OXYGEN SPECIES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84885181935     PISSN: 02724340     EISSN: 15736830     Source Type: Journal    
DOI: 10.1007/s10571-013-9958-z     Document Type: Article

References (26)

1. Benhar M, Engelberg D, Levitzki A (2002) ROS, stress-activated kinases and stress signaling in cancer. EMBO Rep 3(5):420-425. doi: 10.1093/embo- reports/kvf094
2. Bradham C, McClay DR (2006) p38 MAPK in development and cancer. Cell Cycle 5(8):824-828
3. Bulavin DV, Saito S, Hollander MC, Sakaguchi K, Anderson CW, Appella E, Fornace AJ Jr (1999) Phosphorylation of human p53 by p38 kinase coordinates N-terminal phosphorylation and apoptosis in response to UV radiation. EMBO J 18(23):6845-6854. doi: 10.1093/emboj/18.23.6845
4. Cao W, Guo XW, Zheng HZ, Li DP, Jia GB, Wang J (2012) Current progress of research on pharmacologic actions of salvianolic acid B. Chinese journal of integrative medicine 18(4):316-320. doi: 10.1007/s11655-011-012-1052-8
5. Chen YR, Tan TH (2000) The c-Jun N-terminal kinase pathway and apoptotic signaling (review). Int J Oncol 16(4):651-662
6. Chen T, Liu W, Chao X, Zhang L, Qu Y, Huo J, Fei Z (2011) Salvianolic acid B attenuates brain damage and inflammation after traumatic brain injury in mice. Brain Res Bull 84(2):163-168. doi: 10.1016/j.brainresbull.2010.11.015
7. Chen T, Fei F, Jiang XF, Zhang L, Qu Y, Huo K, Fei Z (2012) Down-regulation of Homer1b/c attenuates glutamate-mediated excitotoxicity through endoplasmic reticulum and mitochondria pathways in rat cortical neurons. Free Radical Biol Med 52(1):208-217. doi: 10.1016/j.freeradbiomed.2011.10.451
8. Chiu CC, Chen JY, Lin KL, Huang CJ, Lee JC, Chen BH, Chen WY, Lo YH, Chen YL, Tseng CH, Lin SR (2010) p38 MAPK and NF-kappaB pathways are involved in naphtho[1,2-b] furan-4,5-dione induced anti-proliferation and apoptosis of human hepatoma cells. Cancer Lett 295(1):92-99. doi: 10.1016/j.canlet.2010.02.017
9. Cuadrado A, Lafarga V, Cheung PC, Dolado I, Llanos S, Cohen P, Nebreda AR (2007) A new p38 MAP kinase-regulated transcriptional coactivator that stimulates p53-dependent apoptosis. EMBO J 26(8):2115-2126. doi: 10.1038/sj.emboj.7601657
10. Hallahan AR, Pritchard JI, Chandraratna RA, Ellenbogen RG, Geyer JR, Overland RP, Strand AD, Tapscott SJ, Olson JM (2003) BMP-2 mediates retinoid-induced apoptosis in medulloblastoma cells through a paracrine effect. Nat Med 9(8):1033-1038. doi: 10.1038/nm904
11. Hao Y, Xie T, Korotcov A, Zhou Y, Pang X, Shan L, Ji H, Sridhar R, Wang P, Califano J, Gu X (2009) Salvianolic acid B inhibits growth of head and neck squamous cell carcinoma in vitro and in vivo via cyclooxygenase-2 and apoptotic pathways. Int J Cancer 124(9):2200-2209. doi: 10.1002/ijc.24160
12. Hernandez Losa J, Parada Cobo C, Guinea Viniegra J, Sanchez-Arevalo Lobo VJ, Ramon y Cajal S, Sanchez-Prieto R (2003) Role of the p38 MAPK pathway in cisplatin-based therapy. Oncogene 22(26):3998-4006. doi: 10.1038/sj.onc.1206608
13. Hur JM, Hyun MS, Lim SY, Lee WY, Kim D (2009) The combination of berberine and irradiation enhances anti-cancer effects via activation of p38 MAPK pathway and ROS generation in human hepatoma cells. J Cell Biochem 107(5):955-964. doi: 10.1002/jcb.22198
14. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA 61(2):69-90. doi: 10.3322/caac.20107
15. Mondal S, Bandyopadhyay S, Ghosh MK, Mukhopadhyay S, Roy S, Mandal C (2012) Natural products: promising resources for cancer drug discovery. Anti-Cancer Agents Med Chem 12(1):49-75
16. Olson JM, Hallahan AR (2004) p38 MAP kinase: a convergence point in cancer therapy. Trends Mol Med 10(3):125-129. doi: 10.1016/j.molmed.2004.01.007
17. Park JW, Lee SH, Yang MK, Lee JJ, Song MJ, Ryu SY, Chung HJ, Won HS, Lee CS, Kwon SH, Yun YP, Choi WS, Shin HS (2008) 15,16-dihydrotanshinone I, a major component from Salvia miltiorrhiza Bunge (Dansham), inhibits rabbit platelet aggregation by suppressing intracellular calcium mobilization. Arch Pharmacal Res 31(1):47-53
18. Pelicano H, Carney D, Huang P (2004) ROS stress in cancer cells and therapeutic implications. Drug Resis Updat 7(2):97-110. doi: 10.1016/j.drup.2004.01.004
19. Ralph SJ, Rodriguez-Enriquez S, Neuzil J, Moreno-Sanchez R (2010) Bioenergetic pathways in tumor mitochondria as targets for cancer therapy and the importance of the ROS-induced apoptotic trigger. Mol Aspects Med 31(1):29-59. doi: 10.1016/j.mam.2009.12.006
20. Rock K, McArdle O, Forde P, Dunne M, Fitzpatrick D, O'Neill B, Faul C (2012) A clinical review of treatment outcomes in glioblastoma multiforme - the validation in a non-trial population of the results of a randomised Phase III clinical trial: has a more radical approach improved survival? Br J Radiol 85(1017):e729-e733. doi: 10.1259/bjr/83796755
21. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. New Engl J Med 352(10):987-996. doi: 10.1056/NEJMoa043330
22. Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K, Hau P, Brandes AA, Gijtenbeek J, Marosi C, Vecht CJ, Mokhtari K, Wesseling P, Villa S, Eisenhauer E, Gorlia T, Weller M, Lacombe D, Cairncross JG, Mirimanoff RO (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10(5):459-466. doi: 10.1016/S1470-2045(09)70025- 7
23. Takahashi S, Fusaki N, Ohta S, Iwahori Y, Iizuka Y, Inagawa K, Kawakami Y, Yoshida K, Toda M (2012) Downregulation of KIF23 suppresses glioma proliferation. J Neurooncol 106(3):519-529. doi: 10.1007/s11060-011-0706-2
24. Wagner EF, Nebreda AR (2009) Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer 9(8):537-549. doi: 10.1038/nrc2694
25. Zhao Y, Hao Y, Ji H, Fang Y, Guo Y, Sha W, Zhou Y, Pang X, Southerland WM, Califano JA, Gu X (2010) Combination effects of salvianolic acid B with low-dose celecoxib on inhibition of head and neck squamous cell carcinoma growth in vitro and in vivo. Cancer Prev Res (Phila) 3(6):787-796. doi: 10.1158/1940-6207.CAPR-09-0243
26. Zhao Y, Guo Y, Gu X (2011) Salvianolic acid B, a potential chemopreventive agent, for head and neck squamous cell cancer. J Oncol 2011:534548. doi: 10.1155/2011/534548